These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 11012708)

  • 41. Recombinant activated factor VII (rFVIIa, NovoSeven).
    Agarwal MB; Patnaik M
    J Assoc Physicians India; 2005 Aug; 53():717-20. PubMed ID: 16398083
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An overview of inherited factor VII deficiency.
    Robinson KS
    Transfus Apher Sci; 2019 Oct; 58(5):569-571. PubMed ID: 31447397
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Use of recombinant activated factor VII].
    Reingardiene D; Lazauskas R
    Medicina (Kaunas); 2009; 45(3):248-53. PubMed ID: 19357455
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The evidence behind inhibitor treatment with recombinant factor VIIa.
    Ludlam CA
    Pathophysiol Haemost Thromb; 2002; 32 Suppl 1():13-8. PubMed ID: 12214140
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Recombinant activated factor VII: its mechanism of action and role in the control of hemorrhage.
    Allen GA; Hoffman M; Roberts HR; Monroe DM
    Can J Anaesth; 2002 Dec; 49(10):S7-14. PubMed ID: 12546000
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The use of recombinant factor VIIa in controlling surgical bleeding in non-haemophiliac patients.
    Aldouri M
    Pathophysiol Haemost Thromb; 2002; 32 Suppl 1():41-6. PubMed ID: 12214147
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Congenital FVII deficiency and thrombotic events after replacement therapy.
    Girolami A; Bertozzi I; Rigoni I; Muzzolon R; Vettore S
    J Thromb Thrombolysis; 2011 Oct; 32(3):362-7. PubMed ID: 21681394
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibitor in Congenital Factor VII Deficiency; a Rare but Serious Therapeutic Challenge-A Systematic Literature Review.
    Ramezanpour N; Zaker F; Biswas A; Dorgalaleh A
    J Clin Med; 2021 Jan; 10(2):. PubMed ID: 33435610
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Half-Yearly Report
    Med Phys J; 1813 Jan; 29(167):1-17. PubMed ID: 30493211
    [No Abstract]   [Full Text] [Related]  

  • 50. Continuous infusion of recombinant activated factor VII during caesarean section delivery in a patient with congenital factor VII deficiency.
    Jiménez-Yuste V; Villar A; Morado M; Canales M; Hernández MC; Sanjurjo MJ; Quintana M; Hernández-Navarro F
    Haemophilia; 2000 Sep; 6(5):588-90. PubMed ID: 11012708
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Is prophylaxis required for delivery in women with factor VII deficiency?
    Baumann Kreuziger LM; Morton CT; Reding MT
    Haemophilia; 2013 Nov; 19(6):827-32. PubMed ID: 23607277
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prophylaxis of peripartum haemorrhage using recombinant factor VIIa (rfVIIa) in pregnant women with congenital factor VII deficiency: A case report and literature review.
    Loddo A; Cornacchia S; Cane FL; Barcellona D; Marongiu F; Melis GB; Angioni S; Paoletti AM; Neri M
    Eur J Obstet Gynecol Reprod Biol; 2019 Apr; 235():77-80. PubMed ID: 30831446
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Acquired isolated factor VII deficiency associated with severe bleeding and successful treatment with recombinant FVIIa (NovoSeven).
    Mullighan CG; Rischbieth A; Duncan EM; Lloyd JV
    Blood Coagul Fibrinolysis; 2004 Jun; 15(4):347-51. PubMed ID: 15166922
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Congenital factor VII deficiency: therapy with recombinant activated factor VII -- a critical appraisal.
    Mariani G; Konkle BA; Ingerslev J
    Haemophilia; 2006 Jan; 12(1):19-27. PubMed ID: 16409171
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]     [New Search]
    of 3.